Health and Healthcare
Human Genome Sciences Raising Cash (HGSI)
Published:
Last Updated:
Human Genome Sciences, Inc. (NASDAQ: HGSI) is rasing cash. The company announced that it is selling up to 12.5 million shares of common stock. The company earmarked funds for general corporate purposes, which includes acquisition of additional manufacturing capacity and development of new indications for BENLYSTA, potential sales and marketing activities, clinical trial, research and development, general and administrative and manufacturing expenses. It also said it may use funds to potentially retire debt and said a portion of the proceeds could be for strategic investments.
What is interesting is that the company effectively is trying to say it has no acquisition targets today: “While we evaluate company, product, technology and similar opportunities from time to time, we currently have no material agreements or commitments with respect to any such acquisition or investment.”
But there is more to consider here than companies it wants to acquire. Many investors have hoped that Human Genome’s lupus franchise would get it acquired. If the company is raising cash again, that will potentially take away any extra takeover premium.
Shares are being sold under an existing shelf registration statement. Goldman Sachs and Citigroup are joint book-running managers for the offering, and the underwriters will have a 30-day option to purchase up to an additional 1,875,000 shares of common stock.
It looks like our thought that this eliminates Human Genome as a buyout candidate is a shared one. Shares closed up 2.6% at $27.82, yet shares are trading down close to $26.50 in the after-hours session.
This is likely to put the remaining hopes and rumors for a takeover any time soon to bed.
JON C. OGG
Is Your Money Earning the Best Possible Rate? (Sponsor)
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
